Clin2
NCT06093932Possibly a fitRecruiting

Songling Xuemaikang Capsules for mild high blood pressure

Hypertension,Essential

Part of Heart & circulation clinical trials.

This study tests whether Songling Xuemaikang Capsules can help lower blood pressure in people with mild hypertension who are not currently on regular medication. It may offer a natural treatment option for managing early-stage high blood pressure.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
35 years to 65 years
Study type
Interventional

Who can take part

  • You are between 35 and 65 years old.
  • You have been diagnosed with mild (Grade 1) high blood pressure.
  • You are not taking blood pressure medicine regularly, or you don't take any at all.
  • You are willing to sign a consent form agreeing to join the study.
  • You do not have serious liver, kidney, or other major health problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07709442Not yet recruiting
Study of Songling Xuemaikang for high blood pressure and insomnia

This trial tests a Chinese herbal medicine called Songling Xuemaikang for people who have both high blood pressure and trouble sleeping. It aims to see if the treatment can help lower blood pressure and improve sleep quality.

Beijing
NCT07271732Not yet recruiting
Herbal capsules for brain small vessel disease

This study tests a Chinese herbal capsule for people with high blood pressure and small-vessel disease in the brain. It aims to see if the capsules can help with symptoms like headaches, dizziness, and irritability caused by this condition.

Beijing, Beijing Municipality
NCT07607275Recruiting· Phase 4
Chinese herbal medicine for managing high blood pressure

This trial tests whether a traditional Chinese herbal medicine called Yufeng Ningxin can help lower blood pressure in adults with newly diagnosed or ongoing high blood pressure. Researchers will measure how well it works compared to standard treatment.

Beijing
NCT06425120Recruiting· Phase 4
Xuesaitong for heart disease risk factors

This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.

Beijing, Beijing Municipality
NCT06716970Not yet recruiting· Phase 3
Study of QR12000 tablets for moderate to severe high blood pressure

This study tests an experimental tablet called QR12000 for people with moderate to severe high blood pressure. It aims to see if the treatment is safe and effective. You may join if your blood pressure is not well controlled on your current medicines or if you haven't been treated yet.

Beijing, Beijing Municipality
NCT07152444Not yet recruiting· Phase 1
Testing QLS1410 in healthy adults and those with mild high blood pressure

This trial tests a new drug called QLS1410. It is given once to healthy volunteers and to people with mild high blood pressure to see how the body handles it and if it lowers blood pressure safely.

Beijing

Hear when a new Hypertension,Essential trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.